News

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published today in The Lancet.

Enhancing levels of ‘healthy fats’ like omega-3s in the brain could be beneficial in motor neurone disease (MND) finds a new study in fruit flies and brain cells, led by UCL Queen Square Institute of Neurology researchers.

A new short film documenting the remarkable progress towards a treatment for Motor Neuron Disease (MND), also known as ALS, has been launched.

Trace Neuroscience, a UCL spinout biopharmaceutical company, has received $101m (£78m) in Series A funding, to help develop potential treatments for the most common form of motor neurone disease.

Researchers at the Francis Crick Institute and the UCL Queen Square Institute of Neurology have developed DNA molecules which contain ‘invisibility cloak’ sequences, preventing healthy cells from reading the messages they contain.

During the ENCALS meeting 2024 in Stockholm, Sweden, Prof. Ammar Al-Chalabi awarded two bright researchers: Dr. Rubika Balendra received the gold medal and Dr. Ratko Radakovic received silver.

A new study led by Professor Adrian Isaacs (UCL Queen Square Institute of Neurology and UK DRI at UCL) provides fresh insight into early changes that occur in the brains of people with ALS and FTD, and reveals a response in cells that protects against neurodegeneration

Investigating strange forms of ribonucleic acid (RNA) associated with the formation of aggregates in the brains of ALS patients could lead to new avenues for treatments, a study involving UCL researchers has revealed.

Professor Andrea Malaspina (Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of  Neurology) is part of a team of researchers from the UK and US awarded the Healey International Prize for Innovation in ALS.

We are pleased to announce that My Name’5 Doddie Foundation recently welcomed Professor Rickie Patani of the Francis Crick Institute and UCL to their growing list of Foundation-funded researchers, working to help them achieve their vision of a world free of MND.

A new documentary has been released which follows a key discovery made by researchers at UCL Queen Square Motor Neuron Disease Centre that suggests a promising target for new treatments to tackle motor neuron disease (MND), a terminal condition.

A new research institute to accelerate the search for a cure for motor neuron disease (MND, also known as ALS), launches today in London. ​​​​​​​

Scientists led by UCL Queen Square Institute of Neurology have detailed how a combination of grafted replacement motor neurons and optical nerve stimulation – using light to activate neurons – can improve muscle function in a highly aggressive mouse model of ALS. 

Hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by Motor Neuron Disease (MND), finds a new study by researchers at UCL Queen Square Institute of Neurology and the Francis Crick Institute.

A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND, also known as ALS), is announced today on Global MND Awareness Day.